🔎 Trials Near Me

홈 › 전이성 암 › 오하이오 › Columbus

OH Columbus의 전이성 암 임상 시험

전이성 암 관련 연구 27개가 Columbus 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

피험자 모집 중2상
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • 외 13개
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

피험자 모집 중1상
  • Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05372614

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

피험자 모집 중1상
  • ALX Center 10, Columbus
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07085091

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

피험자 모집 중2/3상
  • The Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06943755

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

피험자 모집 중1/2상
  • Ohio State University, Columbus
12세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

피험자 모집 중3상
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

피험자 모집 중3상
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

SLV-154 Treatment of Advanced Cancers

피험자 모집 중1상
  • The James Outpatient Care West Center, Columbus
12세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06771219

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

피험자 모집 중3상
  • The Mark H Zangmeister Center, Columbus
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10마일 거리
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

피험자 모집 중1/2상
  • Clinical Study Site, Columbus
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT07335497

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

피험자 모집 중3상
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06119581

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

피험자 모집 중1상
  • Ohio State University Hospital, Columbus
18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT06561685

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

피험자 모집 중2상
  • Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06311214

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

피험자 모집 중1상
  • Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05687136

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

피험자 모집 중2상
  • Ohio State University, Columbus
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

피험자 모집 중1상
  • The Ohio State University (OSU), Columbus
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

피험자 모집 중1상
  • Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT05687110

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

피험자 모집 중3상
  • Research Site, Columbus
  • Research Site, Hilliard · 10마일 거리
18세 이상 · 여성 · 2026. 7. 29. 업데이트됨 · NCT07044336

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

피험자 모집 중1상
  • The Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 남성 · 2026. 7. 9. 업데이트됨 · NCT07103018

A Study of LY4175408 in Participants With Advanced Cancer

피험자 모집 중1상
  • The Ohio State University (OSU) Wexner Medical Center, Columbus
18세 이상 · 모든 성별 · 2026. 6. 23. 업데이트됨 · NCT07046923

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

피험자 모집 중1/2상
  • OSU Brain & Spine Hospital, Columbus
12세 이상 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT05384626

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

피험자 모집 중3상
  • Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
18세 이상 · 모든 성별 · 2026. 5. 18. 업데이트됨 · NCT06757634

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

피험자 모집 중3상
  • Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT06064877

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

피험자 모집 중2/3상
  • The Ohio State University, Columbus
전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

피험자 모집 중1상
  • OSU Brain and Spine Hospital, Columbus
18세 이상 · 모든 성별 · 2026. 2. 25. 업데이트됨 · NCT06521554

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

피험자 모집 중3상
  • The Ohio State University Comprehensive Cancer Center, Columbus
18세 이상 · 모든 성별 · 2026. 2. 6. 업데이트됨 · NCT06127407

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

피험자 모집 중관찰 연구
  • Massive Bio SYNERGY-AI site, Columbus
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

다른 도시의 전이성 암 시험

Columbus의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.